China (Mainland)
Assessedsupplier
Crizotinib key intermediate CAS NO.877397-65-4
- Min.Order: 10 Gram
- Payment Terms: L/C,T/T
- Product Details
Keywords
- (S)-1-(2,6-Dichloro-3-fluorophenyl)ethanol
- Chiral Reactive Intermediate
- high purity stable process
Quick Details
- ProName: Crizotinib key intermediate
- CasNo: 877397-65-4
- Molecular Formula: C8H7Cl2FO
- Appearance: white solid
- Application: Crizotinib key intermediate ...
- DeliveryTime: within 4 weeks
- PackAge: standard package
- Port: TBC
- ProductionCapacity: commercial production Metric Ton/Day
- Purity: 99%
- Storage: room temperature
- Transportation: Non-hazardous
- LimitNum: 10 Gram
- Moisture Content: ≤0.5%
- Impurity: ≤1.0%
Superiority
Commercial production from grams to tons， with technical documents package support and audit/inspection support.
All the products we produced with high purity, optimized and stable process.
Details
MW: 209.04
SENOVA PHARMA is committed to the development and production of API’s, advanced intermediates and biochemical products.
We insist on product development and production technology platform combining chemical synthesis (drug synthesis) technology, enzyme synthesis (biocatalytic and biotransformation) technology and microbial fermentation (biosynthesis) technology.
Our own production base and our cooperative plants in China produce products according to cGMP application, providing customers with stable and reliable whole-chain solutions.